Quantitative structure–activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents

Quantitative structure–activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents

Quantitative structure–activity relationship (QSAR) and molecular docking approach were carried out to design novel anti-tuberculosis agents based on xanthone derivatives. QSAR designed new compounds were calculated by Austin Model 1 (AM1) methods and analysis of multi-linear regression (MLR). The r...

Full description

Bibliographic Details
Main Authors:	Emmy Yuanita, Sudirman, Ni Komang Tri Dharmayani, Maria Ulfa, Jufrizal Syahri
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:	Docking QSAR Xanthone Anti-tuberculosis kasA inhibitor
Online Access:	http://www.sciencedirect.com/science/article/pii/S240557942030067X

Similar Items

Molecular Docking of Xanthone Derivatives as Therapeutic Agent for Covid-19
by: Emmy Yuanita, et al.
Published: (2022-03-01)

Biological activity, quantitative structure–activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs
by: Miladiyah I, et al.
Published: (2018-01-01)

Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
by: Pradeep Kumar, et al.
Published: (2018-12-01)

Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design
by: Reshma S. Rudraraju, et al.
Published: (2022-09-01)

One-pot two-component synthesis of halogenated xanthone, 3-o substituted xanthone, and prenylated xanthone derivatives as aromatase inhibitors
by: Shurutishria Ramakrishnan, et al.
Published: (2023-01-01)

Structure–Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
by: Ling-Yun Zhou, et al.
Published: (2018-02-01)

Molecular Docking and Multivariate Analysis of Xanthones as Antimicrobial and Antiviral Agents
by: Freddy A. Bernal, et al.
Published: (2015-07-01)

Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns
by: Ye‛ Zaw Phyo, et al.
Published: (2018-01-01)

Synthesis, characterization and molecular docking of hydroxyxanthone and renylated xanthone derivatives as potential aromatase inhibitor
by: Ramakrishnan, Shurutishria
Published: (2022)

Chiral Derivatives of Xanthones with Antimicrobial Activity
by: Joana Araújo, et al.
Published: (2019-01-01)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
by: Leila Emami, et al.
Published: (2021-01-01)

Molecular Docking and Molecular Dynamic Investigations of Xanthone-Chalcone Derivatives against Epidermal Growth Factor Receptor for Preliminary Discovery of Novel Anticancer Agent
by: Yehezkiel Steven Kurniawan, et al.
Published: (2024-02-01)

Quantitative Structure-Activity Relationship Analysis of Xanthone Derivates as Cytotoxic Agents in Liver Cancer Cell Line HepG2
by: Isnatin Miladiyah, et al.
Published: (2016-05-01)

Naturally occurring pentaoxygenated, hexaoxygenated and dimeric xanthones: a literature survey
by: V. Peres, et al.
Published: (1997-08-01)

Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha
by: Lalit Mohan Nainwal, et al.
Published: (2014-05-01)

Xanthone studies III: Synthesis of some hydroxy and methoxy substituted xanthones /
by: Arends, Peter, et al.

Marine-Derived Xanthone from 2010 to 2021: Isolation, Bioactivities and Total Synthesis
by: Ana C. S. Veríssimo, et al.
Published: (2022-05-01)

QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against <i>Mycobacterium tuberculosis</i>
by: Jhesua Valencia, et al.
Published: (2022-12-01)

Synthetic dimethoxyxanthones bind similarly to human serum albumin compared with highly oxygenated xanthones
by: Otávio Augusto Chaves, et al.
Published: (2024-06-01)

Xanthones from garcinia eugenifolia / M.Taher, Muhammad Sum Idris, Dayar Arbain
by: 174651 M. Taher, et al.

Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular
by: Khaoula Mkhayar, et al.
Published: (2022-11-01)

PRENYLATED XANTHONES FROM Rheedia acuminata
by: Maria das G. B ZOGHBI, et al.
Published: (1993-01-01)

In silico Studies Combining QSAR Models, DFT-based Reactivity Descriptors and Docking Simulations of Phthalimide Congeners with Hypolipidemic Activity
by: Camila da Câmara Lopes, et al.
Published: (2021-07-01)

QSAR modeling, molecular docking, dynamic simulation and ADMET study of novel tetrahydronaphthalene derivatives as potent antitubercular agents
by: Anguraj Moulishankar, et al.
Published: (2023-11-01)

Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer
by: Yadav DK, et al.
Published: (2017-06-01)

Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors
by: Dolores G. Aguila-Muñoz, et al.
Published: (2023-05-01)

QSAR AND MOLECULAR DOCKING STUDY OF GONADOTROPIN-RELEASING HORMONE RECEPTOR INHIBITORS
by: David Ebuka Arthur, et al.
Published: (2022-09-01)

In vitro evaluation, in silico studies and toxicological assay of some xanthones as potential Leishmania donovani inhibitors
by: Marwa S. Osman, et al.
Published: (2022-01-01)

Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin
by: Carla Fernandes, et al.
Published: (2017-05-01)

In-silico design of new enalapril analogs (ACE inhibitors) using QSAR and molecular docking models
by: Jhon Alex Gonzalez Amaya, et al.
Published: (2020-01-01)

Lipoxygenase Inhibition Activity of Coumarin Derivatives—QSAR and Molecular Docking Study
by: Melita Lončarić, et al.
Published: (2020-07-01)

QSAR, molecular docking, and design of novel 4-(N,N-diarylmethyl amines) Furan-2(5H)-one derivatives as insecticides against Aphis craccivora
by: Yusuf Isyaku, et al.
Published: (2020-03-01)

Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
by: Jin Yuanyuan, et al.
Published: (2017-12-01)

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
by: Valeria Catalani, et al.
Published: (2021-07-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-05-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-06-01)

Extractives from Guttiferae : Part XIV, The structures of seven xanthones from the heartwood of Mammea africana L /
by: 425298 Carpenter, I., et al.

Modeling of Re(I) tricarbonyl complexes against SARS-CoV-2 receptor via DFT, in-silico molecular docking, and QSAR
by: Ededet A. Eno, et al.
Published: (2022-12-01)

QSAR and molecular docking studies of novel 2,5-distributed-1,3,4-thiadiazole derivatives containing 5-phenyl-2-furan as fungicides against Phythophthora infestans
by: Yusuf Isyaku, et al.
Published: (2020-04-01)

Combined 3D-QSAR and Molecular Docking Analysis of Thienopyrimidine Derivatives as Staphylococcus aureus Inhibitors
by: Mebarka Ouassaf, et al.
Published: (2021-06-01)